An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies
Type 2 Diabetes News
Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.
47 readers recommended
New ADA guidelines encourage interrupting long periods of sitting: improved blood glucose management and insulin sensitivity
38 readers recommended
Providers and patients will now see the same data - stay tuned for IBM Watson!
38 readers recommended
TCOYD’s CGM Medicare Appeals Assistance Program may be able to help!
56 readers recommended
Plus, a partnership with UCSF to drive better research.
38 readers recommended
# DiabetesEmpowerment: support people with type 2 diabetes by uploading a motivating video, photo, or quote!
62 readers recommended
Available in US physicians’ offices in the next couple weeks; Real-time version submitted to FDA!
35 readers recommended
FDA expands use to people with mild to moderate kidney disease.
52 readers recommended
Understanding the UnitedHealthcare/Medtronic partnership in the context of the Affordable Care Act.
37 readers recommended
College Diabetes Network’s free “Off to College” booklets on overcoming diabetes challenges during the college transition
52 readers recommended
Glucose, food, exercise, and even DIY closed loop on the phone
35 readers recommended
Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...
38 readers recommended
A1c cannot capture the whole picture – hypoglycemia, time in range, and quality of life add so much more!
44 readers recommended
Data from Bluetooth-enabled meter can now be shared with other health tracking apps.
28 readers recommended
Patients with high A1c levels could achieve greater blood glucose control from the start.
77 readers recommended
less risk of diabetes complications, lower A1c, improved weight loss and hypoglycemia; led by Novo Nordisk’s Victoza and semaglutide
32 readers recommended
How will this expansion help tackle urban diabetes worldwide?
55 readers recommended
Close 12-11 vote in favor of label update. Plus, nearly 40% reduction in kidney disease shown at ADA.
30 readers recommended
The First Lady’s ongoing initiatives to improve children’s nutrition, health, and wellbeing
43 readers recommended
Abbott’s free Android app for caregivers is now available